Breaking News

Almac Sciences Extends selectAZyme Offering

Kit contains focussed library of 10 double stranded RNA Ligase enzymes selected from an extended RNAL enzyme panel.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Almac Sciences, a member of the Almac Group, introduced a new capability to synthesise therapeutic oligonucleotides leveraging a new RNA Ligase (RNAL) enzyme kit, extending the company’s selectAZyme enzyme screening collection.    The kit contains a focussed library of 10 double stranded RNA Ligase enzymes, selected from an extended RNAL enzyme panel, and can be used to make single and double stranded RNA— as described in technical paper by Caswell et al. ACS Chem. Biol. 2023, 18(10), 21...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters